Pharma shares bullish; Cipla rises around 3%

NEW DELHI: Pharma shares were trading higher with the Nifty Pharma index up 0.75 per cent at 9287.5 on Friday.

Shares of Cipla (up 2.62 per cent), Divi’s Laboratories (up 1.36 per cent), Lupin (up 0.97 per cent) and Sun Pharmaceutical Industries (up 0.90 per cent) were the top performers in the index.

Piramal Enterprises (up 0.58 per cent), Aurobindo Pharma (up 0.53 per cent) and Biocon (up 0.33 per cent) too were trading with decent gains.

Benchmark NSE Nifty50 index was up 67 points at 10,683.7 while BSE Sensex was up 219.65 points at 35,480.19 around 01:08 pm.

Among the 50 stocks in the Nifty index, 31 were trading in the green, while 18 were in the red.

Shares of YES Bank, Idea Cellular, ICICI Bank, Ashok Leyland, Motherson Sumi, SBI, Bharti Airtel, Bank of Baroda, Axis Bank and RIL were among the most traded shares on the National Stock Exchange.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’